Sign in
MNMD Stock Price, Chart, Stats & News
Mind Medicine (MindMed) Inc.
Save
1.56B
Market cap
–
Current P/E
–
Forward P/E
MNMD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -41.76% |
ROE | -84.39% |
D/E | – |
Interest coverage ratio | -18.84x |
MNMD valuation
P/E | – |
P/S | – |
P/B | 4.81x |
P/CF | -9.92x |
P/FCF | -8.39x |
P/OCF | -9.92x |
PEG | 1.71x |
EV multiple | -9.20x |
About
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments. Among its key pipeline assets is MM-120, currently undergoing Phase 2 clinical trials. This candidate is being investigated for its potential in addressing generalized anxiety disorder, attention deficit hyperactivity disorder (ADHD), and chronic pain.
Similar securities
Based on sector and market capitalization
Report issue